$100 Invested In Moderna 10 Years Ago Would Be Worth This Much Today

Moderna MRNA has outperformed the market over the past 10 years by 35.94% on an annualized basis producing an average annual return of 46.24%. Currently, Moderna has a market capitalization of $71.35 billion.

Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 10 years ago, it would be worth $4,267.82 today based on a price of $185.71 for MRNA at the time of writing.

Moderna's Performance Over Last 10 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.